zur Hausen H. Papillomaviruses in human cancer. Cancer 1987; 59(10): 1692-1696.

Colgan T, Percy M, Suri M. Human papillomavirus infection in morphologically normal cervical epithelium adjacent to squamous dysplasia and invasive carcinoma. Hum Pathol 1989; 20(4): 316- 319.

Konishi I, Fujii S, Nonogaki H, Nanbu Y, Iwai T, Mori T. Immunohistochemical analysis of estrogen receptors, progesterone receptors, Ki-67 antigen, and human papillomavirus DNA in normal and neoplastic epithelium of the uterine cervix. Cancer 1991; 68(6): 1340-1350.

Pao C, Tseng C, Lin C, Yang F, Hor J, Yao D, Hsueh S. Differential expression of telomerase activity in human cervical cancer and cervical intraepithelial neoplasia lesions. J Clin Oncol 1997; 15(5): 1932-1937.

Peyton C, Schiffman M, Lorincz A, Hunt W, Miel zynska I, Bratti C, Eaton S, Hildeshein A, Morera L, Rodriguez A, Herrero R, Sherman M, Wheeler C. Comparison of PCR and hybrid capturebased HPV detection systems using multiple cervical specimen collection strategies. J Clin Microbiol 1998; 36(11): 3248-3254.

Poddighe P, Bulten J, Kerstens H, Robben J, Mel- chers W, Hanselaar A. HPV detection by in situ hybridization signal amplification based on biotinylated tyramine deposition. J Clin Pathol 1996; 49(6): M340-M344.

Selvaggi S. Implications of low diagnostic repro ducibility of cervical cytologic and histologic diagnoses. JAMA 2001; 285(11): 1506-1508.

Snijders P, van Duin M, Walboomers J, Steenbergen R, Risse E, Helmerhorst T, Verheijen R, Meijer C. Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papil lomavirus DNA. Cancer Res 1998; 58(17): 3812-3818.

Sonoda K, Kaku T, Kamura T, Nakashima M, Watanabe T, Nakano H. Tumor associated antigen 22-1-1 expression in uterine cervical squamous neoplasias. Clin Cancer Res 1998; 4(6): 1517-1520.

Berumen J, Unger E, Casas L, Figueroa P. Amplification of human papillomavirus types 16 and 18 in invasive cervical cancer. Hum Pathol 1995; 26(6): 676-681.

Giannoudis A, Herrington CS. Human papilloma virus variants and squamous neoplasia of the cervix. J Pathol 2001; 193(3): 295-302.

Kjellberg L, Wadell G, Bergman F, Isaksson M, Angstrom T, Dillner J. Regular disappearance of the human papillomavirus genome after conization of cervical dysplasia by carbon dioxide laser. Am J Obstet Gynecol 2000; 183(5): 1238-1242.

Mutirangura A, Sriuranpong V, Termrunggraung lert W, Tresukosol D, Lertsaguansinchai P, Voravud N, Niruthisard S. Telomerase activity and human papilloma virus in malignant, premalignant and benign cervical lesions. Br J Cancer 1998; 78(7): 933-939.

Huang C, Qui J, Kashima M, Kurman R, Wu T. Generation of type specific probes for detection of single copy HPV by a novel in situ hybridization method. Mod Pathol 1998; 11(10): 971-977.

Takac I, Marin J, Gorisek B. Human papilloma virus 16 and 18 infection of the uterine cervix in women with different grades of cervical intraepithelial neoplasia (CIN). Int J Gynaecol Obstet 1998; 61(3): 269-273.

Zehbe I, Hacker G, Su H, Hauser-Kronberger C, Hainfeld J, Tubbs R. Sensitive in situ hybridization with catalyzed reporter deposition, streptavidin- nanogold and silver acetate autometallography. Detection of single copy HPV. Am J Pathol 1997; 150(5): 1553-1561.

Iwasawa A, Nieminen P, Lehtinen M, Paavonen J. HPV DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by PCR. Cancer 1996; 77(11): 2275-2279.

Lörincz T. Molecular methods for the detection of human papillomavirus infection. Obstet Gynecol Clin North Am 1996; 23(3): 707-730.

Gall J, Pardue M. Formation and detection of RNA-DNA hybrid molecules in cytological preparations. Proc Natl Acad Sci USA 1969; 63(2): 378-

Huang C, Kashima M, Chen H, Shin I, Kurman R, Wu T. HPV in situ hybridization with catalyzed signal amplification and polymerase chain reaction in establishing cerebellar metastasis of a cervical carcinoma. Hum Pathol 1999; 30(5): 587- 591

Komminoth P, Speel E, Werner M. Target and signal amplification: approaches to increase the sensitivity of in situ hybridization. Histochem Cell Biol 1997; 108(4-5): 325-333.

Sano T, Hikino T, Niwa Y, Kashiwabara K, Oyama T, Fukuda T, Nakajima T. In situ hybridization with biotinylated tyramide amplification: detection of human papillomavirus DNA in cervical neoplastic lesions. Mod Pathol 1998; 11(6): 19-23.

Speel E, Ramaekers C, Hopman A. Sensitive multi color fluorescence in situ hybridization using catalyzed reporter deposition (CARD) amplification. J Histo chem Cytochem 1997; 45(10): 1439-1446.

Holm R. A highly sensitive nonisopotic detection method for in situ hybridization. Appl Immunohistoch Mol Morph 2000; 8(2): 162-165.

Cheung A, Graf A, Hauser-Kronberger C, Dietze O, Tubbs R, Hacker G. Detection of human papillomavirus in cervical carcinoma: comparison of peroxidase, nano gold, and catalyzed reporter deposition (CARD). Mod Pathol 1999; 12(7): 689-696.

Speel E, Hopman A, Komminoth P. Amplification methods to increase the sensitivity of in situ hybridization: play card(s). J Histochem Cytochem 1999; 47(3): 281-288.

Cooper K, Herrington S, Stickland E, Evans F, McGee O. Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridization. J Clin Pathol 1991; 44(12): 990-996.

Unger E, Vernon S, Lee D, Miller D, Reevs W. Detection of HPV in archival tissues: comparison of in situ hybridization and polymerase chain reaction. J Histochem Cytochem 1998; 46(4): 535- 540.

Bewick V, Cheek L, Ball J. Statistics review 8: qualitative data – tests of association. Crit Care 2004; 8(1): 46-53.

Chua K-L, Hjerpe A. Persistence of HPV infections preceding cervical carcinoma. Cancer 1996; 77(1): 121-127.

Evans MF, Aliesky HA, Cooper K. Optimization of biotinyl-tyramide-based in situ hybridization for sensitive background-free applications on formalin-fixed, paraffin-embedded tissue specimens. BMC Clin Pathol 2003; 3(1): 2.

Lizard G, Démares-Poulet MJ, Roignot P, Gambert P. In situ hybridization detection of single-copy human papillomavirus on isolated cells, using a catalyzed signal amplification system: GenPoint. Diagn Cytopathol 2001; 24(2): 112- 116.

Wiedorn K, Kuhl H, Galle J, Caselitz J, Vollmer E Comparison of in-situ hybridization, direct and indirect in-situ PCR as well as tyramide signal amplification for the detection of HPV. Histochem Cell Biol 1999; 111(2): 89-95.

Bettinger D, Bernard B, Riethmuller D, Greslin I, Gay C, Lab M, Seilles E, Mougin C. Human papilloma virus detection by non isotopic in situ hybridization, in situ hybridization with signal amplification and in situ polymerase chain reaction. Eur J Histochem 1999; 43(3): 185-198.

Kawai K, Yaginuma Y, Tsuruoka H, Griffin M, Hayashi H, Ishikawa M. Telomerase activity and human papillomavirus (HPV) infection in human uterine cervical cancers and cervical smears. Eur J Cancer 1998; 34(13): 2082-2086.

Pirog E, Kleter B, Olgac S, Bobkiewicz P, Lindeman J, Quint W, Richart R, Isacson C. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol 2000; 157(4): 1055-1062.

Bosch F, Rohan T, Schneider A, Frazer I, Pfister H, Castellsague X, de Sanjose S, Moreno V, Puig-Tintore L, Smith P, Munoz N, zur Hausen H. Papillomavirus research update: highlights of the Barcelona HPV 2000 international papillomavirus conference. J Clin Pathol 2000; 54(3): 163-175.

Plummer T, Sperry A, Xu H, Lloyd R. In situ hybridization detection of low copy nucleic acid sequences using catalyzed reporter deposition and its usefulness in clinical human papillomavirus typing. Diagn Mol Pathol 1998; 7(2): 76-84.